The global gastroenterology market, valued at USD 35.12 billion in 2024, is projected to surpass USD 53.10 billion by 2031, growing at a CAGR of 6.1%. This growth is driven by the rising prevalence of gastrointestinal disorders such as GERD, IBD, and colorectal cancer, alongside the growing demand for minimally invasive procedures like advanced endoscopy.
Key trends include the integration of AI in diagnostics, such as AI-powered endoscopy tools, and the increasing adoption of biologics and biosimilars for conditions like Crohn’s disease and ulcerative colitis. North America is expected to dominate the market due to high healthcare expenditure and disease prevalence. Leading companies, including Olympus, Medtronic, and GI Alliance, are driving innovation, with developments like AI-enabled diagnostic platforms and enhanced endoscopy imaging systems contributing to improved patient outcomes.
Keep Reading
Add A Comment